International Agency for Research on Cancer (IARC)


Wissenschaftliche/r Akademie / Gesellschaft / Verein

Standort der Organisation:
Lyon, Frankreich


Publikationen in Kooperation mit FAU-Wissenschaftlerinnen und Wissenschaftlern


Yang, Y., Wu, L., Shu, X., Lu, Y., Shu, X.-O., Cai, Q.,... Long, J. (2019). Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk. Cancer Research, 79(3). https://dx.doi.org/10.1158/0008-5472.CAN-18-2726
Haycock, P.C., Burgess, S., Nounu, A., Zheng, J., Okoli, G.N., Bowden, J.,... Smith, G.D. (2017). Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study. JAMA Oncology, 3(5), 636-651. https://dx.doi.org/10.1001/jamaoncol.2016.5945
Shimelis, H., Mesman, R.L.S., Von Nicolai, C., Ehlen, A., Guidugli, L., Martin, C.,... Couch, F.J. (2017). BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer. Cancer Research, 77(11), 2789-2799. https://dx.doi.org/10.1158/0008-5472.CAN-16-2568
Brouckaert, O., Rudolph, A., Laenen, A., Keeman, R., Bolla, M.K., Wang, Q.,... Neven, P. (2017). Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study. Breast Cancer Research, 19(1). https://dx.doi.org/10.1186/s13058-017-0909-3
Wyszynski, A., Hong, C.-C., Lam, K., Michailidou, K., Lytle, C., Yao, S.,... Cole, M.D. (2016). An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression. Human Molecular Genetics, 25(17), 3863-3876. https://dx.doi.org/10.1093/hmg/ddw223
Ghoussaini, M., French, J.D., Michailidou, K., Nord, S., Beesley, J., Canisus, S.,... Edwards, S.L. (2016). Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation. American Journal of Human Genetics, 99(4), 903-911. https://dx.doi.org/10.1016/j.ajhg.2016.07.017
Horne, H.N., Chung, C.C., Zhang, H., Yu, K., Prokunina-Olsson, L., Michailidou, K.,... Figueroa, J.D. (2016). Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus. PLoS ONE, 11(8). https://dx.doi.org/10.1371/journal.pone.0160316
Shi, J., Zhang, Y., Zheng, W., Michailidou, K., Ghoussaini, M., Bolla, M.K.,... Long, J. (2016). Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer. International Journal of Cancer, 139(6), 1303-1317. https://dx.doi.org/10.1002/ijc.30150
Darabi, H., Beesley, J., Droit, A., Kar, S., Nord, S., Marjaneh, M.M.,... Dunning, A.M. (2016). Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs). Scientific Reports, 6. https://dx.doi.org/10.1038/srep32512
Easton, D.F., Lesueur, F., Decker, B., Michailidou, K., Li, J., Allen, J.,... Chenevix-Trench, G. (2016). No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing. Journal of Medical Genetics, 53(5), 298-309. https://dx.doi.org/10.1136/jmedgenet-2015-103529
Liu, J., Loncar, I., Collee, J.M., Bolla, M.K., Dennis, J., Michailidou, K.,... Hollestelle, A. (2016). rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk. Scientific Reports, 6. https://dx.doi.org/10.1038/srep36874
Guo, X., Long, J., Zeng, C., Michailidou, K., Ghoussaini, M., Bolla, M.K.,... Zheng, W. (2015). Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk. Cancer Epidemiology Biomarkers & Prevention, 24(11), 1680-91. https://dx.doi.org/10.1158/1055-9965.EPI-15-0363
Darabi, H., Mccue, K., Beesley, J., Michailidou, K., Nord, S., Kar, S.,... Chenevix-Trench, G. (2015). Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression. American Journal of Human Genetics, 97(1), 22-34. https://dx.doi.org/10.1016/j.ajhg.2015.05.002
Milne, R.L., Burwinkel, B., Michailidou, K., Arias-Perez, J.-I., Pilar Zamora, M., Menendez-Rodriguez, P.,... Easton, D.F. (2014). Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium. Human Molecular Genetics, 23(22), 6096-111. https://dx.doi.org/10.1093/hmg/ddu311
Agarwal, D., Pineda, S., Michailidou, K., Herranz, J., Pita, G., Moreno, L.T.,... Milne, R.L. (2014). FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium. British Journal of Cancer, 110(4), 1088-100. https://dx.doi.org/10.1038/bjc.2013.769
Johnson, N., Dudbridge, F., Orr, N., Gibson, L., Jones, M.E., Schoemaker, M.J.,... Fletcher, O. (2014). Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study. Breast Cancer Research, 16(3), R51. https://dx.doi.org/10.1186/bcr3662
Baumgarten, P., Harter, P.N., Toenjes, M., Capper, D., Blank, A.-E., Sahm, F.,... Mittelbronn, M. (2014). Loss of FUBP1 expression in gliomas predicts FUBP1 mutation and is associated with oligodendroglial differentiation, IDH1 mutation and 1p/19q loss of heterozygosity. Neuropathology and Applied Neurobiology, 40(2), 205-16. https://dx.doi.org/10.1111/nan.12088
Ziegelberger, G., Baum, C., Borkhardt, A., Cobaleda, C., Dasenbrock, C., Dehos, A.,... Weiss, W. (2011). Research recommendations toward a better understanding of the causes of childhood leukemia. Blood Cancer Journal, 1(1). https://dx.doi.org/10.1038/bcj.2010.1

Zuletzt aktualisiert 2017-14-02 um 08:56